17β-estradiol suppresses the macrophage foam cell formation associated with SOCS3

Hormone and Metabolic Research

Volumn 45, Issue 6, 2013, Pages 423-429

  Liang, X ^a   He, M ^a   Chen, T ^a   Wu, Y ^a   Tian, Y ^a   Zhao, Y ^a   Shen, Y ^a   Liu, Y ^a   Yuan, Z ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

ABCA1; estrogen receptors; estrogens; foam cells; SOCS3

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; ESTRADIOL; JANUS KINASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; FOAM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; MACROPHAGE; MACROPHAGE FOAM CELL; MOUSE; NONHUMAN; OVARIECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; CELLS, CULTURED; CHOLESTEROL; DOWN-REGULATION; ESTRADIOL; FEMALE; FOAM CELLS; HUMANS; JANUS KINASE 2; MALE; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

ANIMALIA; MUS;

EID: 84878611320     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1333751     Document Type: Article

References (35)

1. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation: 1997; 95 252 264
2. Hodis H. N., Mack W. J., Lobo R. A., Shoupe D., Sevanian A., Mahrer P. R., Selzer R. H., Liu Cr C. R., Liu Ch C. H., Azen S. P. Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med: 2001; 135 939 953
3. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med: 1991; 325 756 762
4. Marsh M. M., Walker V. R., Curtiss L. K., Banka C. L. Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res: 1999; 40 893 900
5. Bourassa P. A., Milos P. M., Gaynor B. J., Breslow J. L., Aiello R. J. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA: 1996; 93 10022 10027
6. Liao Q., Li X., Zhou S., Liu L., Zhao S., Lian Y., Dong H. Estrogen treatment inhibits vascular endothelial senescence and asymmetrical dimethylarginine in ovariectomized rabbits. J Cardiovasc Pharmacol: 2011; 57 174 182
7. Kavanagh K., Davis M. A., Zhang L., Wilson M. D., Register T. C., Adams M. R., Rudel L. L., Wagner J. D. Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys. Arterioscler Thromb Vasc Biol: 2009; 29 1471 1477
8. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA: 1998; 280 605 613
9. Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix A. Z., Kooperberg C., Stefanick M. L., Jackson R. D., Beresford S. A., Howard B. V., Johnson K. C., Kotchen J. M., Ockene J. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA: 2002; 288 321 333
10. Kolovou G., Giannakopoulou V., Vasiliadis Y., Bilianou H. Effects of estrogens on atherogenesis. Curr Vasc Pharmacol: 2011; 9 244 257
11. Billon-Galés A., Fontaine C., Douin-Echinard V., Delpy L., Berges H., Calippe B., Lenfant F., Laurell H., Guéry J. C., Gourdy P., Arnal JF. Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation: 2009; 120 2567 2576
12. Srivastava RA. Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen. Mol Cell Biochem: 2002; 240 67 73
13. Darabi M., Rabbani M., Ani M., Zarean E., Panjehpour M., Movahedian A. Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy. Gynecol Endocrinol: 2011; 27 701 705
14. Chakrabarti S., Lekontseva O., Davidge ST. Estrogen is a modulator of vascular inflammation. IUBMB Life: 2008; 60 376 382
15. Zhao S. P., Dong S. Z. Effect of tumor necrosis factor alpha on cholesterol efflux in adipocytes. Clin Chim Acta: 2008; 389 67 71
16. Li Y., Schwabe R. F., DeVries-Seimon T., Yao P. M., Gerbod-Giannone M. C., Tall A. R., Davis R. J., Flavell R., Brenner D. A., Tabas I. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem: 2005; 280 21763 21772
17. Reiss A. B., Patel C. A., Rahman M. M., Chan E. S., Hasneen K., Montesinos M. C., Trachman J. D., Cronstein BN. Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Med Sci Monit: 2004; 10 420 425
18. Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A., Hilton DJ. A family of cytokine-inducible inhibitors of signalling. Nature: 1997; 387 917 921
19. Tamiya T., Kashiwagi I., Takahashi R., Yasukawa H., Yoshimura A. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol: 2011; 31 980 985
20. Yoshimura A., Naka T., Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol: 2007; 7 454 465
21. Xue J. H., Yuan Z., Wu Y., Liu Y., Zhao Y., Zhang W. P., Tian Y. L., Liu W. M., Liu Y., Kishimoto C. High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res: 2010; 86 141 150
22. Davidson M. H., Maki K. C., Marx P., Maki A. C., Cyrowski M. S., Nanavati N., Arce JC. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med: 2000; 160 3315 3325
23. Davidson M. H., Maki K. C., Marx P., Maki A. C., Cyrowski M. S., Nanavati N., Arce JC. 17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol: 1997; 17 2679 2684
24. Lundholm L., Movérare S., Steffensen K. R., Nilsson M., Otsuki M., Ohlsson C., Gustafsson J. A., Dahlman-Wright K. Gene expression profiling identifies liver X receptor alpha as an estrogen-regulated gene in mouse adipose tissue. J Mol Endocrinol: 2004; 32 879 892
25. Hao X. R., Cao D. L., Hu Y. W., Li X. X., Liu X. H., Xiao J., Liao D. F., Xiang J., Tang CK. IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis: 2009; 203 417 428
26. Mo Z. C., Xiao J., Liu X. H., Hu Y. W., Li X. X., Yi G. H., Wang Z., Tang Y. L., Liao D. F., Tang CK. AOPPs inhibits cholesterol efflux by down-regulating ABCA1 expression in a JAK/STAT signaling pathway-dependent manner. J Atheroscler Thromb: 2011; 18 796 807
27. Frisdal E., Lesnik P., Olivier M., Robillard P., Chapman M. J., Huby T., Guerin M., Le Goff W. Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J Biol Chem: 2011; 286 30926 30936
28. Adhikari N., Charles N., Lehmann U., Hall J. L. Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury. Curr Atheroscler Rep: 2006; 8 252 260
29. Gharavi N. M., Alva J. A., Mouillesseaux K. P., Lai C., Yeh M., Yeung W., Johnson J., Szeto W. L., Hong L., Fishbein M., Wei L., Pfeffer L. M., Berliner J. A. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J Biol Chem: 2007; 282 31460 31468
30. Kremer J. M., Bloom B. J., Breedveld F. C., Coombs J. H., Fletcher M. P., Gruben D., Krishnaswami S., Burgos-Vargas R., Wilkinson B., Zerbini C. A., Zwillich S. H. The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo. Arthritis Rheum: 2009; 60 1895 1905
31. Sandborn W. J., Ghosh S., Panes J., Vranic I., Su C., Rousell S., Niezychowski W. Study A3921063 Investigators. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med: 2012; 367 616 624
32. Leung K. C., Doyle N., Ballesteros M., Sjogren K., Watts C. K., Low T. H., Leong G. M., Ross R. J., Ho KK. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA: 2003; 100 1016 1021
33. Leong G. M., Moverare S., Brce J., Doyle N., Sjögren K., Dahlman-Wright K., Gustafsson J. A., Ho K. K., Ohlsson C., Leung KC. Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro. Endocrinology: 2004; 145 5525 5531
34. Tomoka Yamamoto Hideo, Yasukawa Mitsuhisa, Koga Yusuke, Sugi Daisuke, Fukui Nobuyoshi, Futamata Nobuhiro, Tahara Hisashi. Kai, Tsutomu Imaizumi. Abstract 911: Lacking SOCS3 Gene in Macrophages Prevents the Development of Atherosclerosis in ApoE Deficient Mice. Circulation. 2007; 116: II-179
35. Ortiz-Muñoz G., Martin-Ventura J. L., Hernandez-Vargas P., Mallavia B., Lopez-Parra V., Lopez-Franco O., Muñoz-Garcia B., Fernandez-Vizarra P., Ortega L., Egido J., Gomez-Guerrero C. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol: 2009; 29 525 531